What happened
On Monday, Epizyme(NASDAQ:EPZM) shares were hit with the one-two punch of an earnings miss and a major change in leadership. In late afternoon trading, the stock of the cancer drug specialist was down by nearly 10%.
So what
Epizyme released…

Click here to view the original article.